Skip to main content

Neuroinflammation and Biomarker Discovery

From Mechanisms to Clinical Application

  • 1st Edition - March 1, 2027
  • Latest edition
  • Editors: Arun Kumar Singh, Meenakshi Dhanawat
  • Language: English

Neuroinflammation and Biomarker Discovery: From Mechanisms to Clinical Application offers a detailed exploration of the molecular and cellular processes underlying neuroi… Read more

Back to School

Start strong. Study with purpose.

Save up to 25% on trusted learning resources

Description

Neuroinflammation and Biomarker Discovery: From Mechanisms to Clinical Application offers a detailed exploration of the molecular and cellular processes underlying neuroinflammatory conditions. This essential reference addresses the urgent need for advanced biomarkers that can facilitate early diagnosis, monitor disease progression, and guide personalized treatments in neurodegenerative and autoimmune disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The book synthesizes current knowledge on neuroimmune interactions, glial cell activation, blood-brain barrier integrity, and innate immune signaling pathways, providing a comprehensive framework for understanding neuroinflammatory mechanisms. It also covers state-of-the-art platforms for biomarker discovery, including transcriptomics, proteomics, lipidomics, epigenomics, extracellular vesicles, and neuroimaging techniques, emphasizing their translational potential. The inclusion of disease-specific biomarker landscapes enhances its relevance for clinicians and researchers working in diagnostics and drug development. The final sections focus on translational applications, such as clinical trial design, biomarker validation, and the integration of AI-driven multi-omics data for personalized neuroimmunology. This volume is an indispensable resource for neuroscientists, clinicians, graduate students, biotech professionals, and data scientists seeking to advance understanding and innovation in neuroinflammatory research and clinical practice. By bridging basic science and clinical application, it aims to accelerate the development of targeted therapies and diagnostic tools, ultimately improving patient outcomes in neuroinflammatory diseases

Key features

  • Explains neuroinflammatory mechanisms at molecular and cellular levels
  • Connects research findings to clinical diagnostics and therapeutic strategies
  • Provides disease-specific biomarker profiles for neurodegenerative and autoimmune disorders
  • Highlights cutting-edge imaging platforms for biomarker discovery

Readership

Neuroscientists and clinicians specializing in neurodegenerative diseases

Table of contents

SECTION I: MOLECULAR AND CELLULAR FRAMEWORK OF NEUROINFLAMMATION

1. The Neuroimmune Axis: Cellular Interfaces and Bidirectional Signaling

2. Microglial Activation States: From Homeostasis to Neurotoxicity

3. Astrocyte and Oligodendrocyte Contribution to Neuroinflammation

4. Pattern Recognition Receptors and CNS Innate Immunity

5. Molecular Triggers: DAMPs, PAMPs, and the Inflammasome Complex

6. Blood-Brain Barrier Breakdown and Immune Cell Trafficking

SECTION II: SIGNALING NETWORKS IN NEUROINFLAMMATORY PATHWAYS

7. NF-κB and MAPK Pathways: Master Regulators of Inflammatory Transcription

8. JAK/STAT Signaling and Interferon Regulatory Networks in the CNS

9. Redox Signaling, ROS Generation, and Mitochondrial Dysfunction

10. Autophagy, Ubiquitin-Proteasome System, and Immune Regulation

SECTION III: ADVANCED PLATFORMS FOR BIOMARKER DISCOVERY

11. Transcriptomic Approaches: Bulk RNA-Seq and Single-Cell Resolution

12. Proteomics and Phosphoproteomics in Neuroinflammation

13. Lipidomics and Metabolomics of Inflammatory Brain States

14. Epigenomic Biomarkers: DNA Methylation, Histone Modifications, and miRNAs

15. Extracellular Vesicles and Exosomal Biomarkers in Neuroinflammatory Diseases

16. Imaging Biomarkers: PET, MRI, and Molecular Neuroimaging

SECTION IV: DISEASE-SPECIFIC BIOMARKER LANDSCAPES

17. Neuroinflammation in Alzheimer's Disease: Aβ, Tau, and Microglial Dysfunction

18. Biomarkers of Neuroinflammation in Parkinson’s Disease and Lewy Body Disorders

19. Multiple Sclerosis and Autoimmune Neuroinflammation

20. Stroke, Traumatic Brain Injury, and Post-Injury Neuroinflammation

21. Vascular Ageing and its Impact on Brain Health

22. Epstein–Barr Virus (EBV) and Multiple Sclerosis

23. Herpes Simplex Virus (HSV) and Alzheimer's Disease

SECTION V: TRANSLATIONAL APPLICATIONS AND FUTURE DIRECTIONS

24. Biomarkers in Clinical Trials: Stratification, Monitoring, and Endpoints

25. Toward Personalized Neuroimmunology: AI-Driven Integration of Multi-Omics Data

Product details

  • Edition: 1
  • Latest edition
  • Published: March 1, 2027
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, India

MD

Meenakshi Dhanawat

Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with many years of experience in Pharmaceutical Sciences and Medicinal Chemistry. She completed her Master's degree at NIPER, Mohali, focusing on glycosylamino acids, and earned her Ph.D. from IIT-BHU, Varanasi, investigating CNS drug delivery targeting 5HT1A/2A receptors. Her research encompasses synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction. Dr. Dhanawat has received notable international recognition, including a travel grant from the AAPS Drug Delivery and Development section for the 2010 National Biotechnology Conference in California, and international travel grants from DBT and DST, Government of India, for conferences in California and Munich. Her distinguished honors include the Rajiv Gandhi National Fellowship, affirming her sustained contributions to pharmaceutical research and academic excellence.
Affiliations and expertise
Associate Professor, Amity Institute of Pharmacy, Amity University, Haryana, India